mRNA Analytical Services
Curia utilizes leading technological methods for analyzing mRNA
- Curia offers comprehensive platforms for analyzing your products from early stage through drug substance and drug product release criteria.
- We provide both GMP and non-GMP testing proficiencies, specifically tailored for each phase of development.
- Our team prioritizes collaboration and transparent communication, enabling you to stay informed and engaged.
- On-site analytics deliver rapid turnaround times to keep your project moving.
- Our integrated approach covers all phases of drug development, including early-phase testing, customized manufacturing processes, and clinical batch release.